Search

everythinglearnresearchcommunity

for

Search:↓

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Finasteride and dutasteride both increase chromogranin A levels similarly.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Vaginal surgeries generally did not significantly change women's sexual quality of life.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Higher DHT levels are linked to worse heart changes in severe aortic valve stenosis patients.

Long-term diabetes is linked to lower prostate cancer risk.

Finasteride is safe for long-term use in prostate cancer treatment.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Proper precautions can prevent hair loss after robotic gynecological surgery.

Finasteride can cause serious side effects in some men, needing more research for treatment.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Finasteride reduces bleeding during prostate surgery.

Post-finasteride syndrome is rare but serious and should be taken seriously.

Post-finasteride syndrome causes sexual, physical, and psychological symptoms, but more research is needed to understand its causes and connection to finasteride.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Finasteride reduces low-grade prostate cancer but may not be beneficial overall.

Post-finasteride syndrome can cause lasting sexual, physical, and mental health issues with limited treatment options.

Presurgical models can effectively and affordably screen cancer prevention agents.

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.